ES2556253B2 - Preparaciones antifúngicas destinadas al tratamiento local de onicomicosis - Google Patents
Preparaciones antifúngicas destinadas al tratamiento local de onicomicosis Download PDFInfo
- Publication number
- ES2556253B2 ES2556253B2 ES201531001A ES201531001A ES2556253B2 ES 2556253 B2 ES2556253 B2 ES 2556253B2 ES 201531001 A ES201531001 A ES 201531001A ES 201531001 A ES201531001 A ES 201531001A ES 2556253 B2 ES2556253 B2 ES 2556253B2
- Authority
- ES
- Spain
- Prior art keywords
- local
- antifungal preparations
- onychomycosis
- preparations intended
- onychomycosis treatment
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7015—Drug-containing film-forming compositions, e.g. spray-on
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Dermatology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR1401569A FR3023484B1 (fr) | 2014-07-11 | 2014-07-11 | Preparations antifongiques destinees au traitement local des onychomycoses |
| FR140156 | 2014-07-11 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| ES2556253A2 ES2556253A2 (es) | 2016-01-14 |
| ES2556253R1 ES2556253R1 (es) | 2016-02-02 |
| ES2556253B2 true ES2556253B2 (es) | 2016-09-19 |
Family
ID=52358801
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES201531001A Expired - Fee Related ES2556253B2 (es) | 2014-07-11 | 2015-07-10 | Preparaciones antifúngicas destinadas al tratamiento local de onicomicosis |
Country Status (3)
| Country | Link |
|---|---|
| CH (1) | CH709877B1 (fr) |
| ES (1) | ES2556253B2 (fr) |
| FR (1) | FR3023484B1 (fr) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP6800209B2 (ja) | 2015-08-13 | 2020-12-16 | ビーエイエスエフ・ソシエタス・エウロパエアBasf Se | 水溶性溶媒、無機増粘剤及びアルコキシレートを含む非水性殺有害生物剤懸濁液 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4672078A (en) * | 1985-07-03 | 1987-06-09 | Schering-Plough Corporation | Urea stabilized with a lactone in various pharmaceutical and cosmetic preparations |
| HU200914B (en) * | 1987-03-09 | 1990-09-28 | Horvath Gyoengyi Lengyelne | Process for producing new medical dosage unit suitable for local treatment of fungus infection of nails |
| US5487776A (en) * | 1994-03-17 | 1996-01-30 | Nimni; Marcel | Anti-fungal nail lacquer and method therefor |
| US6197098B1 (en) * | 1999-12-16 | 2001-03-06 | Isp Investments Inc. | Fast drying biocidal preservative composition |
| MXPA03004049A (es) * | 2003-05-08 | 2004-11-10 | Acosta Rita Guadal Escorihuela | Composicion topica para el tratamiento de micosis en las unas y procedimiento de obtencion. |
| WO2010091045A2 (fr) * | 2009-02-05 | 2010-08-12 | Advanced Technology Materials, Inc. | Composition ne contenant pas de fluorure pour l'élimination de polymères et autres matières organiques à partir d'une surface |
| RU2601896C2 (ru) * | 2013-04-30 | 2016-11-10 | Закрытое Акционерное Общество "Вертекс" | Комбинированный препарат для лечения грибковых заболеваний ногтей |
-
2014
- 2014-07-11 FR FR1401569A patent/FR3023484B1/fr not_active Expired - Fee Related
-
2015
- 2015-07-10 CH CH01003/15A patent/CH709877B1/fr not_active IP Right Cessation
- 2015-07-10 ES ES201531001A patent/ES2556253B2/es not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| FR3023484A1 (fr) | 2016-01-15 |
| ES2556253A2 (es) | 2016-01-14 |
| ES2556253R1 (es) | 2016-02-02 |
| CH709877A2 (fr) | 2016-01-15 |
| CH709877B1 (fr) | 2019-04-30 |
| FR3023484B1 (fr) | 2018-10-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CL2021001575A1 (es) | Pirazolopirimidinas sustituidas y purinas sustituidas y su uso como inhibidores de proteasa procesadora específica de ubiquitina 1 (usp1) | |
| CL2020002512A1 (es) | Tratamiento de la hidradenitis supurativa mediante el uso de inhibidores de jak. | |
| CL2019001674A1 (es) | Inhibidores de imidazopirazina de tirosina quinasa de bruton. | |
| MX2018011102A (es) | Combinaciones de inhibidores de desmetilasa-1 especifica de lisina (lsd1) para uso en el tratamiento de tumores solidos. | |
| CL2019001079A1 (es) | Métodos para usar indazol-3-carboxamidas y su uso como inhibidores de la vía de señalización de wnt/b-catenina. | |
| CL2013003227A1 (es) | “compuestos derivados de indazol sustituidos, moduladores de la actividad de proteínas quinasas; proceso de obtención de ellos; método in vitro para inhibir proteínas quinasas; composición y combinación farmacéutica que los comprende; y su uso en el tratamiento del cáncer" pct | |
| BR112018014281A2 (pt) | agentes, usos e métodos para o tratamento da sinucleinopatia | |
| UY33346A (es) | Compuestos y metodos para la modulacion de quinasa e indicaciones de la misma | |
| PE20161032A1 (es) | Anticuerpos anti-tau(ps422) humanizados y metodos de utilizacion | |
| BR112016018205A8 (pt) | métodos de tratamento de mal de alzheimer, de seleção de pacientes, de identificação de pacientes, de previsão, de otimização da eficácia terapêutica, kit, uso de agente e uso in vitro de agente | |
| UY36561A (es) | Nuevas proteínas específicas para pioverdina y pioquelina | |
| UY32030A (es) | "tratamiento para diabetes en pacientes inapropiados para terapia con metformina" | |
| ECSP13012436A (es) | ANTICUERPOS PEPTÍDICOS BETA AMILOIDE ANTI-N3pGlu Y USOS DE LOS MISMOS | |
| GT201300080A (es) | Proceso de elaboracion para derivados de pirimidina | |
| BR112017022526A2 (pt) | uso de uma composição de tratamento capilar | |
| BR112016002287A2 (pt) | compostos terapeuticamente ativos e seus métodos de uso | |
| AR092188A1 (es) | ANTICUERPOS HUMANOS PARA GFRa3 Y METODOS PARA SU USO | |
| AR092899A1 (es) | Uso de masitinib para el tratamiento del cancer en subpoblaciones de pacientes identificados que utilizan factores de prediccion | |
| ES2525137B1 (es) | Agentes para tratar el mieloma múltiple | |
| CO2020009524A2 (es) | Formulación de adenovirus del grupo b | |
| MX2019010707A (es) | Metodos para tratar y/o prevenir queratosis actinica. | |
| BR112018011851A2 (pt) | compostos de isoindol | |
| EA201992562A1 (ru) | Пептиды для лечения сахарного диабета | |
| EA201390287A1 (ru) | Теобромин в комбинации с отхаркивающим или муколитическим средствами для применения в терапии | |
| CO2024000581A2 (es) | Comprimido que comprende una sal del ácido n-(8-(2-hidroxibenzoil)amino)caprílico |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG2A | Definitive protection |
Ref document number: 2556253 Country of ref document: ES Kind code of ref document: B2 Effective date: 20160919 |
|
| FD2A | Announcement of lapse in spain |
Effective date: 20250826 |